Cornercap Investment Counsel’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-17,985
Closed -$589K 652
2022
Q2
$589K Sell
17,985
-29,725
-62% -$939K 0.1% 362
2022
Q1
$1.25M Buy
47,710
+963
+2% +$23.5K 0.14% 182
2021
Q4
$1.11M Buy
46,747
+2,834
+6% +$69.9K 0.16% 243
2021
Q3
$1.1M Buy
43,913
+23,253
+113% +$592K 0.13% 288
2021
Q2
$537K Buy
+20,660
New +$562K 0.06% 469
2021
Q1
Sell
-55,505
Closed -$1.83M 697
2020
Q4
$1.83M Buy
+55,505
New +$1.09M 0.26% 120
2020
Q3
Sell
-59,381
Closed -$1.3M 545
2020
Q2
$1.3M Sell
59,381
-5,163
-8% -$118K 0.21% 130
2020
Q1
$1.49M Buy
64,544
+664
+1% +$19.3K 0.29% 110
2019
Q4
$2.11M Sell
63,880
-490
-0.8% -$15.7K 0.28% 111
2019
Q3
$2.05M Sell
64,370
-365
-0.6% -$10.6K 0.29% 108
2019
Q2
$1.66M Buy
64,735
+10,035
+18% +$256K 0.22% 145
2019
Q1
$1.39M Buy
+54,700
New +$1.63M 0.19% 157
2017
Q2
Sell
-17,925
Closed -$704K 397
2017
Q1
$704K Hold
17,925
0.12% 166
2016
Q4
$624K Buy
+17,925
New +$704K 0.11% 224

Other funds holding NTUS

Cornercap Investment Counsel's NTUS Position: Q3 2022 in Review

Cornercap Investment Counsel sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 17,985 shares — an estimated $589K sold.

Cornercap Investment Counsel first reported a position in NTUS in Q4 2016 and held it in 14 quarters. The position peaked at $2.11M in Q4 2019. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Cornercap Investment Counsel reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Cornercap Investment Counsel sold 17,985 Natus Medical Inc shares in Q3 2022, an estimated $589K.
  • Cornercap Investment Counsel first reported a position in Natus Medical Inc in Q4 2016 and held it in 14 quarters.
  • Cornercap Investment Counsel's Natus Medical Inc position peaked at $2.11M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Cornercap Investment Counsel's 13F filing for Q3 2022, filed 14 Nov 2022.